Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
3,196
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness of nivolumab monotherapy in the third-line treatment of small cell lung cancer

Caitlin Smarea HEOR, Parexel International, London, UKCorrespondence[email protected]
,
Kiran Davea HEOR, Parexel International, London, UK
,
Ariadna Juarez-Garciab Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UK
,
Pranav Abrahamc Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA
,
John R. Penrodc Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA
,
D. Ross Camidged Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver, CO, USA
&
Yong Yuanc Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA
 show all
Pages 1124-1133 | Received 15 Sep 2020, Accepted 27 Aug 2021, Published online: 30 Sep 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.